Edap Tms (NASDAQ:EDAP) Releases Earnings Results, Beats Estimates By $0.06 EPS

Edap Tms (NASDAQ:EDAP) posted its quarterly earnings results on Thursday. The medical equipment provider reported ($0.05) EPS for the quarter, beating the consensus estimate of ($0.11) by $0.06, Zacks reports. The business had revenue of $22.69 million during the quarter, compared to analyst estimates of $20.83 million. Edap Tms had a negative net margin of 34.92% and a negative return on equity of 44.21%.

Edap Tms Stock Performance

Shares of NASDAQ EDAP opened at $2.15 on Friday. Edap Tms has a 12-month low of $1.96 and a 12-month high of $8.50. The company has a market cap of $79.77 million, a PE ratio of -3.31 and a beta of 0.37. The stock has a 50 day simple moving average of $2.42 and a 200-day simple moving average of $2.51. The company has a current ratio of 2.18, a quick ratio of 1.46 and a debt-to-equity ratio of 0.08.

Wall Street Analysts Forecast Growth

Several equities analysts have recently commented on EDAP shares. StockNews.com assumed coverage on Edap Tms in a report on Friday. They set a “hold” rating for the company. Piper Sandler lowered their price objective on Edap Tms from $5.00 to $4.50 and set an “overweight” rating for the company in a research note on Friday. Finally, HC Wainwright reiterated a “buy” rating and issued a $19.00 target price on shares of Edap Tms in a research note on Friday.

Edap Tms Company Profile

EDAP TMS SA is a holding company, which, through its subsidiary, engages in the development, production, and marketing of minimally invasive medical devices for urological diseases. It operates through the High Intensity Focused Ultrasound (HIFU) and Urology Devices and Services (UDS) segments. The HIFU segment develops, manufactures, and markets devices for the minimally invasive ablation of certain types of localized tumors using HIFU technology.